Einsatz der Bisphosphonate in der Orthopädie und Unfallchirurgie

CME
Literatur
1. Aspenberg P (2006) Pharmacological
treatment of osteonecrosis. Acta
Orthop 77: 175–176
2. Bartl C, Bartl R, Salzmann G, Imhoff
A (2008) Treatment of painful bone
marrow edema syndrome with intravenous
ibandronate. Bone (Suppl
1) 42: 112
3. Bartl R (2007) Leitliniengerechtes
Management der Osteoporose: Rationell
– kostensparend – effektiv.
Dtsch Med Wochenschr 132: 995–
999
4. Bartl R, Bartl C, Mutschler W (2002)
Diagnostik und Therapie der Osteoporose:
Strategie für eine effiziente
Prävention von Folgefrakturen.
Unfallchirurg 106: 526–1543
5. Bartl R, Frisch B (1993) Biopsy of
bone in internal medicine – An atlas
and sourcebook. Kluwer Academic,
Dordrecht Boston London
6. Bartl R, Frisch B, Tresckow E von,
Bartl C (2007) Bisphosphonates in
medical practice. Springer, Berlin
Heidelberg New York
7. Bartl R, Mast G (2008) Bisphosphonate-associated
osteonecrosis of
the jaw: a pathophysiologic approach.
Bone (Suppl 1) 42: 165
8. Bhandari M, Bajammal S, Guyatt G
et al. (2005) Effect of bisphosphonates
on periprosthetic bone mineral
density after total joint arthroplasty.
J Bone Joint Surg Am A-87:
293–301
9. Black D, Delmas P, Eastell R et al.
(2007) Once-yearly zoledronic acid
for treatment of postmenopausal
osteoporosis. N Engl J Med 356:
1809–1822
10. Body J, Bartl R, Burckhardt P et al.
(1998) Current use of bisphosphonates
in oncology: International Bone
and Cancer Study Group. J Clin
Oncol 16: 3890–3899
11. Cao Y, Mori S, Mashiba T et al.
(2002) Raloxifene, estrogen, and
alendronate affect the processes
of fracture repair differently in ovariectomized
rats. J Bone Miner Res
17: 2237–2246
12. Felsenberg D, Hoffmeister B, Amling
M et al. (2006) Kiefernekrosen
nach hoch dosierter Bisphosphonattherapie.
Dtsch Arztebl 103:
2681–2682
13. Fleisch H (2000) Bisphosphonates
in bone disease, 4th edn. Academic
Press, San Diego
14. Hilding M, Aspenberg P (2007) Local
perioperative treatment with a
bisphosphonate improves the fixation
of total knee prostheses: a randomized,
double-blind radiostereometric
study of 50 patients. Acta
Orthop 78: 795–799
15. Kanis J, Burlet N, Cooper C et al.
(2008) European guidance for the
diagnosis and management of osteoporosis
in postmenopausal osteoporosis.
Osteoporos Int 19: 399–
428
16. Köck F, Borisch N, Koester B, Grifka
J (2003) Das komplexe regionale
Schmerzsyndrom Typ I (CRPS I): Ursachen,
Diagnostik und Therapie.
Orthopade 32: 418–431
17. Lee Y, Low S, Lim L et al. (2001) Cyclic
pamidronate infusion improves
bone mineralization and reduces
fracture incidence in osteogenesis
imperfecta. Eur J Pediatr 160: 641–
644
18. Little D, Cornell M, Briody J et al.
(2001) Intravenous pamidronate
reduces osteoporosis and improves
formation of the regenerate during
distraction osteogenesis. J Bone
Joint Surg Br 83: 1069–1074
19. Lyles K, Conon-Emeric C, Magaziner
J et al. (2007) Zoledronic acid and
clinical fractures and mortality after
hip fracture. N Engl J Med 357:
1799–1809
20. Major P, Lortholary A, Hon J et al.
(2001) Zoledronic acid is superior
to pamidronate in the treatment
of hypercalcemia of malignancy: a
pooled analysis of two randomized,
controlled clinical trial. J Clin Oncol
19: 558–567
21. Marini J (2003) Do bisphosphonates
make children’s bones better
or brittle? N Engl J Med 349: 423–
426
22. Mont M, Jones L, Hungerford D
(2006) Nontraumatic osteonecrosis
of the femoral head: ten years later.
J Bone Joint Surg Am 88: 1117–
1132
23. Moroni A, Faldini C, Hoang-Kim A
et al. (2007) Alendronate improves
screw fixation in osteoporotic bone.
J Bone Miner Res 89-A: 96–101
24. Morris C, Einhorn T (2005) Bisphosphonates
in orthopedic surgery. J
Bone Joint Surg Am 87: 1609–1618
25. Reid I, Miller P, Lyles K et al. (2005)
A single infusion of zoledronic acid
improves remission rates in Paget’s
disease. A randomized controlled
comparison with risedronate. N
Engl J Med 353: 898–908
26. Schott G (1997) Bisphosphonates
for pain relief in reflex sympathetic
dystrophy? Lancet 350: 1117
27. Sundfeldt M, Carlsson L, Johansson
C et al. (2006) Aseptic loosening,
not only a question of wear. A review
of different theories. Acta Orthop
77: 177–197
28. Tanzer M, Kerabasz D, Krygier J et al.
(2005) Bone augmentation around
and within porous implants by local
bisphosphonate elution. Clin
Orthop 441: 30–39
29. Teitelbaum S (2000) Bone resorption
by osteoclasts. Science 289:
1504–1508
30. Wang C, Wang J, Weng L (2003) The
effect of alendronate on bone mineral
density in the distal part of
the femur and proximal part of the
tibia after total knee arthroplasty. J
Bone Joint Surg Am 85: 2121–2126
bruar - März - April - Mai
- Juni - Juli - Aug
gust - September - Okto
Gewusst?
Online Gewinnspiel
Testen Sie Ihr Medizinvokabular:
springer.de/gewusst
Der Orthopäde 6 · 2008 |
613